Pages that link to "Q36145180"
Jump to navigation
Jump to search
The following pages link to Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2 (Q36145180):
Displaying 50 items.
- Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic 'eat-me' signals: cleavage and inhibition of phagocytosis by Lp-PLA2 (Q23923069) (← links)
- Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology (Q26827400) (← links)
- To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase (Q26865969) (← links)
- The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism (Q28072835) (← links)
- Action mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studies (Q28077812) (← links)
- Organization of the Mammalian Metabolome according to Organ Function, Lineage Specialization, and Longevity (Q28604105) (← links)
- Impact of 8-week linoleic acid intake in soy oil on Lp-PLA2 activity in healthy adults. (Q33651282) (← links)
- Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation (Q33696583) (← links)
- Lp-PLA2 Inhibitors for the Reduction of Cardiovascular Events (Q33936097) (← links)
- Anti-inflammatory therapies for cardiovascular disease (Q34137872) (← links)
- Anti-psoriatic therapy recovers high-density lipoprotein composition and function (Q34259215) (← links)
- Microinflammation factors in the common diseases of the heart and kidneys (Q35025893) (← links)
- Apolipoprotein CIII regulates lipoprotein-associated phospholipase A2 expression via the MAPK and NFκB pathways (Q35616605) (← links)
- Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis (Q35856590) (← links)
- Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort (Q35879822) (← links)
- The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia (Q35927066) (← links)
- Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease. (Q36933725) (← links)
- Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes (Q37112920) (← links)
- A phenome-wide association study of a lipoprotein-associated phospholipase A2 loss-of-function variant in 90 000 Chinese adults (Q37401167) (← links)
- Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes (Q37431606) (← links)
- Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome (Q37713531) (← links)
- Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies (Q37720776) (← links)
- Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes (Q38103488) (← links)
- Emerging anti-inflammatory drugs for atherosclerosis (Q38106998) (← links)
- Novel metabolic biomarkers of cardiovascular disease (Q38245327) (← links)
- New and emerging biomarkers in cardiovascular disease (Q38586900) (← links)
- Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity. (Q38682093) (← links)
- Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection (Q38707328) (← links)
- After the LEADER trial and SUSTAIN-6, how do we explain the cardiovascular benefits of some GLP-1 receptor agonists? (Q38826068) (← links)
- ω3-polyunsaturated fatty acids suppress lipoprotein-associated phospholipase A2 expression in macrophages and animal models (Q38870156) (← links)
- Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke (Q38951255) (← links)
- Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor. (Q39011074) (← links)
- Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein (Q39153624) (← links)
- Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease in a multi-ethnic cohort: The Multi-Ethnic Study of Atherosclerosis (Q40328826) (← links)
- The putative phospholipase Lip2 counteracts oxidative damage and influences the virulence of Ustilago maydis (Q40765119) (← links)
- Evaluation of carotid intima-media thickness and carotid arterial stiffness in children with adenotonsillar hypertrophy (Q40865332) (← links)
- The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice (Q42755958) (← links)
- Unraveling the PAF-AH/Lp-PLA2 controversy (Q43204699) (← links)
- New lipid and lipoprotein targets for the treatment of cardiometabolic diseases (Q43237185) (← links)
- The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk (Q44819479) (← links)
- Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression. (Q46290391) (← links)
- Resveratrol suppresses lipoprotein-associated phospholipase A2 expression by reducing oxidative stress in macrophages and animal models (Q46352015) (← links)
- Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children (Q46590378) (← links)
- The effect of Danshen extract on lipoprotein-associated phospholipase A2 levels in patients with stable angina pectoris: study protocol for a randomized controlled trial - the DOLPHIN study (Q47164065) (← links)
- Lactonase Activity and Lipoprotein-Phospholipase A2 as Possible Novel Serum Biomarkers for the Differential Diagnosis of Autism Spectrum Disorders and Rett Syndrome: Results from a Pilot Study (Q47291057) (← links)
- Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome (Q48033119) (← links)
- Activity and distribution of plasma platelet-activating factor acetylhydrolase in women with gestational diabetes mellitus and their neonates (Q48880495) (← links)
- Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids. (Q50089193) (← links)
- Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis. (Q50719449) (← links)
- Effects of apoC1 genotypes on the hormonal levels, metabolic profile and PAF-AH activity in Chinese women with polycystic ovary syndrome. (Q52595654) (← links)